A detailed history of Bank Of America Corp transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of America Corp holds 65,576 shares of ANIP stock, worth $3.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,576
Previous 25,664 155.52%
Holding current value
$3.61 Million
Previous $1.63 Million 139.41%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$54.33 - $65.72 $2.17 Million - $2.62 Million
39,912 Added 155.52%
65,576 $3.91 Million
Q2 2024

Aug 14, 2024

BUY
$58.53 - $68.82 $779,912 - $917,026
13,325 Added 107.99%
25,664 $1.63 Million
Q1 2024

May 15, 2024

SELL
$54.2 - $69.69 $717,770 - $922,904
-13,243 Reduced 51.77%
12,339 $852,000
Q4 2023

Feb 14, 2024

BUY
$48.72 - $65.43 $269,372 - $361,762
5,529 Added 27.57%
25,582 $1.41 Million
Q2 2023

Aug 14, 2023

SELL
$37.29 - $53.83 $193,162 - $278,839
-5,180 Reduced 20.53%
20,053 $1.08 Million
Q1 2023

May 12, 2023

SELL
$37.61 - $45.72 $112 - $137
-3 Reduced 0.01%
25,233 $1 Million
Q4 2022

Feb 10, 2023

BUY
$31.9 - $41.95 $294,915 - $387,827
9,245 Added 57.81%
25,236 $1.02 Million
Q3 2022

Nov 14, 2022

SELL
$29.83 - $38.01 $55,036 - $70,128
-1,845 Reduced 10.34%
15,991 $514,000
Q2 2022

Aug 12, 2022

BUY
$23.09 - $33.46 $130,181 - $188,647
5,638 Added 46.22%
17,836 $529,000
Q1 2022

May 16, 2022

BUY
$26.91 - $47.15 $66,333 - $116,224
2,465 Added 25.33%
12,198 $343,000
Q4 2021

Feb 08, 2022

SELL
$32.97 - $56.85 $157,200 - $271,060
-4,768 Reduced 32.88%
9,733 $448,000
Q3 2021

Nov 15, 2021

BUY
$26.48 - $35.99 $179,746 - $244,300
6,788 Added 88.01%
14,501 $476,000
Q2 2021

Sep 13, 2021

BUY
$31.86 - $38.6 $245,736 - $297,721
7,713 New
7,713 $270,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $960M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.